Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): Gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion

Seminars in Arthritis and Rheumatism

Volumn 14, Issue 1, 1984, Pages 1-23

  Masi, Alfonse T ^a   Josipovic, Dragojlo B ^b   Jefferson, William E ^a  

^a Department of Medicine ^*  (United States)

^b Formerly UTCHS Research Fellow in Rheumatology USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

11 DEOXY 17 OXOSTEROID URINE LEVEL; ENDOCRINE SYSTEM; ETIOLOGY; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; JOINT; MAJOR CLINICAL STUDY; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; ANABOLIC AGENTS; ANDROGENS; ANDROSTERONE; ARTHRITIS, RHEUMATOID; CALORIMETRY; CHROMATOGRAPHY, GAS; CORTODOXONE; DEHYDROEPIANDROSTERONE; ETIOCHOLANOLONE; FEMALE; GLUCOCORTICOIDS; HUMANS; METYRAPONE; MIDDLE AGED; PREGNANEDIOL; PREGNANETRIOL;

EID: 0021634085     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(84)90005-2     Document Type: Article

References (102)

1. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthritis
2. The ameliorating effect of pregnancy and jaundice on certain rheumatic diseases
3. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report
4. Current status of steroid therapy in rheumatic disorders
5. Treatment of rheumatoid arthritis with cortisone
6. The secretion rate of cortisol in patients with rheumatoid arthritis
7. Epidemiology of the rheumatic diseases
8. 1958 revision of diagnostic criteria for rheumatoid arthritis
9. Psychological state and body size as determinants of 17-OHCS excretion
10. Drug interference with measurement of adrenal hormones in urine: Analgesics and tranquilizer sedatives
11. Effect of low dose cortisol therapy on epinephrine excretion in man
12. Use of intravenous ACTH Study in quantitative adrenocortical stimulation
13. Clinical application of a new test of pituitary reserve
14. 2 · CO in urine extracts as an indication of androgen content
15. Determination of urinary 17-ketogenic steroids by means of sodium metaperiodate oxidation
16. Urinary steroids
17. The effect of ibuprofen on the excretion of steroid metabolites
18. Therapeutic criteria in rheumatoid arthritis
19. Standardization of the latex test for rheumatoid arthritis serology
20. Metabolism of 11 β-hydroxyandrostenedione, adrenosterone and hydrocortisone to urinary 11-oxy-17-ketosteroids
21. Analysis of total, grouped, and individual urinary 17-ketosteroids: A critical evaluation
22. Some factors determining the adrenal response to Metyrapone (SU 4885)
23. Fractionation of urinary ketosteroids: Procedure and clinical significance
24. Decreased conversion of androgens to normal 17-ketosteroid metabolites: A nonspecific consequence of illness
25. The interaction of pregnancy and the rheumatic diseases
26. The fetal adrenal gland
27. Urinary excretion of dehydroepiandrosterone in normal and abnormal late pregnancy and in nonpregnant women
28. Articular patterns in the early course of rheumatoid arthritis
29. Aging and urinary steroid excretion
30. Testosterone secretion and metabolism in male senescence
31. The normal levels of 17-hydroxycorticosteroids in the peripheral blood of man
32. Pathogenesis of rheumatoid arthritis
33. Hormonal influences on immunologic and related phenomena
34. Rheumatoid arthritis
35. DR antigen distribution in blacks with rheumatoid arthritis
36. HLA antigens and rheumatoid arthritis
37. Some aspects of the H-2 system the major histocompatibility system in the mouse
38. HLA and adrenal disease
39. Pathogenesis of rheumatoid arthritis: A vascular hypothesis
40. Sex effects in systemic lupus erythematosus—A clue to pathogenesis
41. Low plasma androgens in women with active or quiescent systemic lupus erythematosus
42. Low androgen levels in females with active systemic lupus erythematosus (SLE)
43. Androgen plasma levels in female rheumatoid arthritis patients
44. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulfate in man
45. Urinary steroids of healthy subjects from childhood to old age: Age-controlled changes of urinary steroids
46. Radioimmunoassay of plasma pregnenolone, 17-hydroxypregnenolone and dehydroepiandrosterone under various physiological conditions
47. Female hormones reduce neutrophil responsiveness in vitro
48. Rheumatoid arthritis: The relevance of clinical knowledge to research activities
49. Hormonal disturbances associated with rheumatoid arthritis and related conditions
50. Adrenal function in rheumatoid arthritis
51. Urinary excretion of 17-hydroxy-20-oxosteroids in normal health and in rheumatoid arthritis
52. Therapeutic efficacy of † 5- Pregnenolone in rheumatoid arthritis Preliminary observations
53. Effects of delta 5 pregnenolone in rheumatoid arthritis
54. Prednisolone metabolism and rheumatoid arthritis
55. Corticosteroid metabolism and rheumatoid arthritis
56. Staub PL, Menthe JW, Nelson SS et al: Excretion of 11-oxycorticosteroids in paraplegic and rheumatoid arthritis patients. J Clin Invest 29: 349–350
57. Corticosteroid metabolism and rheumatoid arthritis
58. The hypophysis in rheumatoid arthritis
59. The syndrome of hypopituitarism
60. Arthritis and panhypopituitarism
61. Evidence for existence of cortical androgen-stimulating hormone
62. Hirsutism and hyperandrogenism
63. Adrenal androgen excess and defective 11 β-hydroxylation in women with idiopathic hirsutism
64. The 17-ketosteroid excretion in rheumatoid arthritis
65. The effect of trauma and disease on the urinary 17-ketosteroid excretion in man
66. Studies on adrenal cortical activity in patients with rheumatoid arthritis: The diurnal pattern and twenty-four hour levels of urinary total 17-hydroxycorticosteroids and 17-ketosteroids
67. Corticosteroids in rheumatoid arthritis: Studies on aldosterone, 17-hydroxycorticosteroid, and 17-ketosteroid response to corticotropin in male patients with rheumatoid arthritis
68. The 17-ketosteroid/17-hydroxycorticosteroid ratio as a useful measure of the physiological age of the human adrenal cortex
69. Urinary steroid excretion in rheumatoid arthritis: Changes in ketonic and non-ketonic fractions during hormone therapy
70. Steroid excretion patterns in rheumatoid arthritis
71. Low-dosage glucocorticoid therapy: An appraisal of its safety and mode of action in clinical disorders, including rheumatoid arthritis
72. Excretion of individual 17-ketosteroids in rheumatoid arthritis
73. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency
74. Study on the inactivation mechanism of androgens in rheumatoid arthritis: Excretory rate of free and conjugated 17-ketosteroids
75. Protein-corticosteroid interactions in peripheral plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis
76. Plasma dehydroepiandrosterone dehydroepiandrosterone sulfate and androsterone sulfate levels and their interaction with plasma proteins in rheumatoid arthritis
77. Role of ACTH in the secretion of free dehydroepiandrosterone and its sulfate ester in man
78. Adrenarche: Changing adrenal response to adrenocorticotrophin
79. Andrenocortical function in old age: Response to acute adrenocorticotropin stimulation
80. Metabolism and interconversion of dehydroepiandrosterone and dehydroepiandrosterone sulfate
81. Effect of dehydrepiandrosterone on hereditary angioedema
82. Influence of metyrapone on plasma concentrations of testosterone and androstenedione in man
83. Steroidogenesis and cell structure Biochemical pursuit of steroid brosynthesis
84. 17,20-lyase cytochrome P-450
85. Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of a C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase)
86. Purification and properties of 17 alpha-hydroxylase from microsomes of pig adrenal: A second C21 side-chain cleavage system
87. Enhancement of gonadotropin induced 17,20-lyase suppression one week after human chorionic gonadotropin priming
88. Inhibition of testicular microsomal cytochrome P-450 (17 alpha-hydroxylase/C-17,20 lyase) by estrogens
89. Gonadotropin stimulation of pregnenolone metabolism in Chinese hamster ovary cells in culture
90. Two types of male pseudohermaphroditism due to 1720-desmolase deficiency
91. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase
92. Factors affecting sex hormone levels in postmenopausal women
93. Hypergonadotrophic hypogonadism in an XX female subject due to 17,20 steroid desmolase deficiency
94. Partial deficiency of 17,20 lyase activity in a eunuchoid, eumenorrheic female with delayed bone age
95. Genetic analysis of 24 multiple case families with rheumatoid arthritis
96. A procedure for comprehensive analysis of neutral urinary steroids in endocrine investigations
97. Automated qualitative and quantitative metabolic profiling analysis of urinary steroids by a gas chromatography-mass spectrometry-data system
98. Determination of cortisol in human plasma by reverse phase high-performance liquid chromatography
99. Oestrogens, the menopause, and the adrenopause
100. Androgen and glucocorticoid receptors in human skeletal muscle cytosol